"Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)"
Clinical trial NCT05299580 · WITHDRAWN
Trial details
- NCT number
- NCT05299580
- Sponsor
- Fondazione Melanoma Onlus
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2023-03-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.